XML 61 R39.htm IDEA: XBRL DOCUMENT v3.24.0.1
Leases (Tables)
12 Months Ended
Dec. 31, 2023
Leases [Abstract]  
Summary of the Components of Net Lease Cost and Supplemental Cash Flow Information
The following table is a summary of the components of net lease cost for the years ended December 31, 2023, 2022 and 2021:
In millions202320222021
Operating lease cost$2,532 $2,579 $2,633 
Finance lease cost:
Amortization of right-of-use assets84 79 62 
Interest on lease liabilities73 68 62 
Total finance lease costs157 147 124 
Short-term lease costs22 27 25 
Variable lease costs635 610 604 
Less: sublease income(63)(61)(59)
Net lease cost$3,283 $3,302 $3,327 

Supplemental cash flow information related to leases for the years ended December 31, 2023, 2022 and 2021 was as follows:
In millions202320222021
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows paid for operating leases$2,756 $2,689 $2,714 
Operating cash flows paid for interest portion of finance leases73 68 62 
Financing cash flows paid for principal portion of finance leases70 62 50 
Right-of-use assets obtained in exchange for lease obligations:
Operating leases1,132 591 1,254 
Finance leases(4)232 278 
Supplemental Balance Sheet Information
Supplemental balance sheet information related to leases as of December 31, 2023 and 2022 is as follows:
In millions, except remaining lease term and discount rate20232022
Operating leases:
Operating lease right-of-use assets (1)
$17,252$17,928
Current portion of operating lease liabilities$1,741$1,699
Long-term operating lease liabilities16,03416,839
Total operating lease liabilities (2)
$17,775$18,538
Finance leases:
Property and equipment, gross$1,604$1,608
Accumulated depreciation(375)(284)
Property and equipment, net$1,229$1,324
Current portion of long-term debt$66$59
Long-term debt1,3251,406
Total finance lease liabilities$1,391$1,465
Weighted average remaining lease term (in years)
Operating leases11.412.2
Finance leases17.319.4
Weighted average discount rate
Operating leases4.5 %4.4 %
Finance leases5.0 %4.9 %
_____________________________________________
(1)Includes operating lease right-of-use assets of $56 million which were accounted for as assets held for sale and were included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 ‘‘Acquisitions, Divestitures and Asset Sales’’ for additional information.
(2)Includes current portion of operating lease liabilities of $21 million and long-term operating lease liabilities of $39 million which were accounted for as liabilities held for sale and were included in liabilities held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 ‘‘Acquisitions, Divestitures and Asset Sales’’ for additional information.
Maturities of Operating Lease Liabilities
The following table summarizes the maturity of lease liabilities under finance and operating leases as of December 31, 2023:
In millionsFinance
Leases
Operating
Leases
(1)
Total
2024$143 $2,716 $2,859 
2025138 2,559 2,697 
2026130 2,369 2,499 
2027127 2,181 2,308 
2028124 2,024 2,148 
Thereafter1,446 11,004 12,450 
Total lease payments (2)
2,108 22,853 24,961 
Less: imputed interest(717)(5,078)(5,795)
Total lease liabilities$1,391 $17,775 $19,166 
_____________________________________________
(1)Future operating lease payments have not been reduced by minimum sublease rentals of $289 million due in the future under noncancelable subleases.
(2)The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.1 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.
Maturities of Finance Lease Liabilities
The following table summarizes the maturity of lease liabilities under finance and operating leases as of December 31, 2023:
In millionsFinance
Leases
Operating
Leases
(1)
Total
2024$143 $2,716 $2,859 
2025138 2,559 2,697 
2026130 2,369 2,499 
2027127 2,181 2,308 
2028124 2,024 2,148 
Thereafter1,446 11,004 12,450 
Total lease payments (2)
2,108 22,853 24,961 
Less: imputed interest(717)(5,078)(5,795)
Total lease liabilities$1,391 $17,775 $19,166 
_____________________________________________
(1)Future operating lease payments have not been reduced by minimum sublease rentals of $289 million due in the future under noncancelable subleases.
(2)The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.1 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.